One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Physician Preferences for Lower-Quality Kidney Offers.
Kelly, Diana
doi : 10.2215/CJN.0000000000000336
Volume 18(12) pgs. 1519-1644 December 2023
Maximizing Utility of Deceased Donor Kidney Offers.
Caldwell, Jillian S.; Cheng, Xingxing S.
Does Gender-Affirming Hormone Therapy Affect the Kidney?.
Collister, David 1,2,3,4; Ahmed, Sofia B. 4,5
Treating Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome: To Obi or Not to Obi, That is the Question.
Robinson, Cal H. 1,2; Parekh, Rulan S. 1,2,3
Dialysis Vascular Access and Critical Distal Ischemia.
Vachharajani, Tushar J. 1; Tan, Tze-Woei 2
Nurse Practitioner Care Compared with Primary Care or Nephrologist Care in Early CKD.
James, Matthew T. 1,2,3,4; Scory, Tayler D. 1; Novak, Ellen 1; Manns, Braden J. 1,2,3,4; Hemmelgarn, Brenda R. 5; Bello, Aminu K. 5; Ravani, Pietro 1,2,3; Kahlon, Bhavneet 1; MacRae, Jennifer M. 1,2,4; Ronksley, Paul E. 1,2,3
Cystatin C-Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals.
van Eeghen, Sarah A. 1,2; Wiepjes, Chantal M. 1,2; T'Sjoen, Guy 3; Nokoff, Natalie J. 4; den Heijer, Martin 1,2; Bjornstad, Petter 4,5; van Raalte, Daniel H. 2,6,7
Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children.
Dossier, Claire 1; Bonneric, Stephanie 1; Baudouin, Veronique 1; Kwon, Theresa 1; Prim, Benjamin 1; Cambier, Alexandra 1; Couderc, Anne 1; Moreau, Christelle 2; Deschenes, Georges 1; Hogan, Julien 1,3
Interstitial Eosinophilic Aggregates and Kidney Outcome in Patients with CKD.
Hattori, Koki 1; Sakaguchi, Yusuke 1; Oka, Tatsufumi 1; Asahina, Yuta 1; Kawaoka, Takayuki 1; Yamamoto, Ryohei 1,2; Matsui, Isao 1; Mizui, Masayuki 1; Kaimori, Jun-Ya 1; Isaka, Yoshitaka 1
Characteristics of Complement Protein Deposition in Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition.
Liu, Meng-yao 1,2,3,4,5; Yu, Xiao-juan 1,2,3,4,5; Wang, Su-xia 1,2,3,4,5,6; Li, Yuan 7; Xing, Guo-lan 7; Chen, Ming 1,2,3,4,5; Zhou, Fu-de 1,2,3,4,5; Zhao, Ming-hui 1,2,3,4,5,8
Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy.
Kang, Yuqi; Xu, Boyang; Shi, Sufang; Zhou, Xujie; Chen, Pei; Liu, Lijun; Li, Yebei; Leng, Yueqi; Lv, Jicheng; Zhu, Li; Zhang, Hong
Vascular Access-Related Distal Ischemia Requiring Intervention: Frequency, Risk Factors, and Consequences.
Allon, Michael 1; Cutter, Gary R. 2; Young, Carlton J. 3
Physician Preferences when Selecting Candidates for Lower-Quality Kidney Offers.
Gonzalez Sepulveda, Juan M. 1,2; Mehrotra, Sanjay 3; Yang, Jui-Chen 2; Schantz, Karolina J. 4; Becker, Yolanda 5; Formica, Richard 6; Ladner, Daniela P. 7; Kaufman, Dixon 8; Friedewald, John 7
Facility Closures and Distance Traveled to Receive Dialysis Care in the United States.
Niu, Jingbo 1; Worsley, Melandrea 1; Rosales, Omar 2; Oluyomi, Abiodun 2; Erickson, Kevin F. 1,3
Pregnancy and Family Policies in Nephrology Fellowships.
Jain, Koyal 1; Pivert, Kurtis A. 2; Burgner, Anna M. 3; Halbach, Susan M. 4; Weidemann, Darcy K. 5; Boyle, Suzanne M. 6
System-Level Strategies to Improve Home Dialysis: Policy Levers and Quality Initiatives.
Watnick, Suzanne 1,2,3; Blake, Peter G. 4,5; Mehrotra, Rajnish 2; Mendu, Mallika 6; Roberts, Glenda 2; Tummalapalli, Sri Lekha 7,8; Weiner, Daniel E. 9; Butler, Catherine R. 2,3
HRSA Pushes OPTN Reforms as Criticism of US Organ Transplantation System Increases.
Adashi, Eli Y. 1; Bayliss, George 1,2
Kidney Preservation Strategies to Improve Transplant Outcomes.
Longchamp, Alban; Markmann, James F.
Blocking Aldosterone Synthesis: Whose BrigHTN Idea Was That?.
Townsend, Raymond R.
How I Treat Tumor Lysis Syndrome.
Joseph, Adrien 1; Zafrani, Lara 1,2
End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.
Langman, Craig B. 1; Assimos, Dean 2; Blank, Melanie 3; Calle, Juan 4; Grauer, Andreas 5; Kausz, Annamaria 6; Milliner, Dawn 7; Nazzal, Lama 8; Smith, Kimberly 9; Tasian, Greg 10; Thompson, Aliza 11; Wood, Kyle D. 2; Worcester, Elaine 12; Yang, Sixun 13; Malley, Meaghan A. 14; Knauf, Felix 15; Lieske, John C. 7,16; on behalf of the Rare Kidney Stone Consortium (RKSC) Kidney Health Initiative (KHI) Oxalosis and Hyperoxaluria Foundation Enteric Hyperoxaluria Workgroup (OHF EH Workgroup); Assimos, Dean; Calle, Juan; Cowley, Helena; Dahl, Naomi; Grauer, Andreas; Hollander, Kim; Langman, Craig; Lieske, John; McClean, Lacy; Milliner, Dawn; Nazzal, Lama; Puurunen, Marja; Wheeler, Alistair; Wood, Kyle; Yocum, Richard; Zeid, Joumana
